Fig. 2From: Clinical detection and categorization of uncommon and concomitant mutations involving BRAFDistribution of kinase-activated, kinase-impaired and kinase-unknown BRAF mutants. Non-small cell lung cancers (NSCLCs) showed higher incidences of kinase-impaired and kinase-unknown BRAF mutants as compared to colorectal cancers (CRCs) and melanomasBack to article page